China
FDA expands list of valsartan recalls
August 9, 2018Medical Communications China, FDA, US, heart medication, recall, valsartan
The US Food and Drug Administration (FDA) has expanded a list of products containing valsartan that are to be recalled. …
Top Ten most popular articles on Pharmafile.com this week
July 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, China, GSK, Gilead, J&J, JJ, Pfizer, Remicade, Roche, antimicrobial resistance, biosimilar, pharma, pricing, viagra
With the UK in the grip of a record-breaking heatwave, it’s hard to focus on much else over here, but …
Chinese premier slams drug maker after vaccine scandal
July 23, 2018Sales and Marketing CCP, China, biotech, scandal, vaccines
Chinese Premier Li Keqiang has spoken out against drug maker Changsheng Biotechnology after the Chinese firm was found to have …
China opens market to Indian drugs with reduced tariffs
July 10, 2018Manufacturing and Production, Sales and Marketing China, India, pharma
India and China have reached an agreement aimed at reducing tariffs on Indian pharmaceuticals going between the world’s two most …
Sanofi invests €66m in Chinese R&D hub
July 3, 2018Manufacturing and Production China, Sanofi, chengdu, development, pharma, research
French multinational Sanofi is investing €66 million in a tech-focused operation in China in an effort to increase efficiency and …
BMS’ Opdivo becomes first immuno-oncology agent available in China
June 18, 2018Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, China, NSCLC, lung cancer, oncology, opdivo, pharma
Bristol-Myers Squibb’s flagship immunotherapy Opdivo (nivolumab) has broken ground to become the first and only PD-1 inhibitor to be made …
Eli Lilly partners with Chinese institution to advance the nation’s diabetes and CVD care
April 27, 2018Medical Communications, Research and Development China, Eli Lilly, cardiovascular disorders, cvd, diabetes, pharma, type 2 diabetes
EIi Lilly has announced plans to partner up with China’s National Center for Cardiovascular Diseases (NCCD), the nation’s institution responsible …
Mundipharma signs Chinese licensing and distribution agreement with Grünenthal
January 16, 2018Manufacturing and Production China, Grunenthal, Mundipharma, Tramal, pharma
US-based firm Mundipharma is set to take over commercialisation and distribution duties for the analgesic Tramal (tramadol) in China on …
Gilead launches hep C drug Sovaldi in China at one-fifth of US price
November 29, 2017Research and Development, Sales and Marketing China, Gilead, hepatitis C, pharma, sovaldi
Gilead has officially launched its hepatitis C drug Sovaldi (sofosbuvir) in the Chinese market, but with one major caveat: it …
China to accelerate drug approvals with overseas trial data
October 9, 2017Research and Development, Sales and Marketing China, drug approvals, pharma, pharmaceuticals
In a bid to speed up access to medicines for patients, China has revealed it intends to incorporate data from …
China’s Fosun Group grabs 74% stake in India’s Gland Pharma for $1.1 billion
September 18, 2017Sales and Marketing China, Fosun Pharma, Gland Pharma, India, pharma, pharmaceuticals
Chinese conglomerate Fosun has agreed to acquire 74% of India’s Gland Pharma for $1.1 billion, sealing a previously unsuccessful deal …
China’s distribution changes force major US company out
July 25, 2017Manufacturing and Production, Sales and Marketing Cardinal Health, China, biotech, distribution, drugs, pharma, pharmaceutical
Cardinal Health, one of the largest drug distributors in the US, is looking to sell on its network in China, …
Superbugs in the supply chain
May 26, 2017Medical Communications Antibiotics, Changing Markets, China, IMAGE: Changing Markets, Superbugs
Bad Manufacturing Practices: Changing Markets examines China’s role in the antibiotics supply chain and the damaging pollution that results from …
China threatens prison time and death penalty to fight fraudulent trial data
May 12, 2017Medical Communications, Research and Development, Sales and Marketing China
In a drastic move to help solve its notorious problem with fraudulent clinical trial data, China has introduced a policy …
China proposes ways to speed up approval for imported drugs
March 20, 2017Sales and Marketing China, imported drugs
It can currently take up to three or four years for a new drug to reach market in China, slowing …
